Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03104842
Title Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitatsklinikum Hamburg-Eppendorf
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.